Phase 1 clinical trial dosing of first patient complete; primary objective to assess safety/tolerability and absolute bioavailability of TH104Phase 1

ANAHEIM, CA / ACCESSWIRE / February 5, 2024 / Mesa Home Resources, Inc. (OTC PINK:MHRE) (“Mesa” or the “Company”) is

NEW YORK, NY / ACCESSWIRE / February 5, 2024 / INNODATA INC. (NASDAQ:INOD) a leading data engineering company, announced that

ORLANDO, FL / ACCESSWIRE / February 5, 2024 / PureCycle Technologies, Inc. (Nasdaq:PCT) (the “Company”), today announced that PureCycle: Ohio

JACKSON, WY / ACCESSWIRE / February 5, 2024 / Labor Smart, Inc. (OTC PINK:LTNC) through its wholly-owned subsidiary, Next Gen

BOSTON, MA / ACCESSWIRE / February 5, 2024 / Physician Growth Partners (“PGP”), a leading sell-side healthcare investment banking and

Completed Factory Acceptance Test and Now Working Toward Commercial OperationsDALLAS, TX / ACCESSWIRE / February 5, 2024 / Vivakor, Inc.

ABBOTT PARK, IL / ACCESSWIRE / February 5, 2024 / Abbott:AbbottThe PROTALITY™ brand provides nutritional support for adults pursuing weight